Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1081710]Researchers: A/Pr Xiao-Jun Du (Principal investigator)
Brief description Cardiac fibrosis is a key factor promoting heart disease and onset of complications including arrhythmias and heart failure. There is urgent and unmet need of drugs that can reverse fibrosis. By documenting anti-fibrotic action of a peptide hormone relaxin, CIA and his team will test therapeutic effect of relaxin in heart disease models focusing on fibrosis-reversal and functional gain, particularly arrhythmias. This work would promote development of relaxin as a new cardiovascular drug.
Funding Amount $AUD 724,754.67
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1081710
- PURL : https://purl.org/au-research/grants/nhmrc/1081710
